AquaBounty Technologies, Inc. (AQB)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
AquaBounty Technologies, Inc. (AQB) trades at $1.02 with AI Score 24/100 (Grade F). AquaBounty Technologies, Inc. focuses on enhancing productivity in the commercial aquaculture industry. Market cap: $3.96M, Sector: Consumer defensive.
Price live · AI analysis from Jun 1, 2026Analyst Coverage for AQB: AQB does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates AQB against Consumer Defensive peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
AQB: 4/7 perspectives are bearish. Dominant signal: Seth Klarman bearish.
How is this calculated? →AquaBounty Technologies, Inc. (AQB) Consumer Business Overview
AquaBounty Technologies, Inc. operates within the agricultural farm products sector, specializing in bioengineered Atlantic salmon. Their AquAdvantage Salmon aims to enhance productivity in the aquaculture industry, primarily serving the United States and Canada. The company focuses on genetic research and the sale of salmon products.
What Is the Investment Thesis for AQB?
AquaBounty Technologies presents a unique investment opportunity within the aquaculture industry, driven by its innovative AquAdvantage Salmon. The key value driver is the potential for increased production efficiency and reduced time-to-market compared to traditional salmon farming. Growth catalysts include expanding production capacity and securing regulatory approvals in new markets. However, investors may want to evaluate the risks associated with consumer acceptance of genetically engineered food and the regulatory hurdles involved in bringing novel products to market. With a market capitalization of $3.96M and a beta of 1.31, AquaBounty exhibits moderate volatility. The lack of a dividend reflects the company's focus on reinvesting earnings for growth. The company's success hinges on scaling production and gaining wider market acceptance of its AquAdvantage Salmon.
Based on FMP financials and quantitative analysis
AQB Key Highlights
- AquaBounty Technologies focuses on enhancing productivity in the commercial aquaculture industry.
- The company's primary product is AquAdvantage Salmon, a bioengineered Atlantic salmon for human consumption.
- AquaBounty sells conventional Atlantic salmon, salmon eggs, fry, and byproducts.
- The company engages in genetic, genomic, and fish health and nutrition research activities.
- AquaBounty Technologies has a market capitalization of $3.96M and a beta of 1.31.
Who Are AQB's Competitors?
AQB is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| SALM Salem Media Group, Inc. | $0.97 | +0.14% | $25.46M | 51 |
| FSRCY First Resources Limited | $238.46 | +0.00% | $3.69B | 64 |
| FTROF First Resources Limited | $1.80 | -20.35% | $2.79B | 64 |
| CALM Cal-Maine Foods, Inc. | $83.98 | +0.16% | $3.98B | 64 |
| UOLI Uonlive Corporation | $5.75 | +0.00% | 63 | |
| WLMIF Wilmar International Limited | $2.78 | +0.00% | $17.36B | 46 |
| TSN Tyson Foods, Inc. | $58.63 | -0.44% | $20.87B | 47 |
| ORENF Origin Enterprises plc | $4.86 | +0.00% | $522.39M | 48 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are AQB's Key Strengths?
- Innovative AquAdvantage Salmon technology.
- First mover advantage in GE salmon market.
- Strong intellectual property protection.
- Focus on sustainable aquaculture practices.
What Are AQB's Weaknesses?
- Limited production capacity.
- Dependence on a single product.
- Negative consumer perception of genetically engineered food.
- Regulatory hurdles in new markets.
What Could Drive AQB Stock Higher?
- Expansion of production capacity at existing facilities.
- Potential regulatory approvals in new geographic markets by Q4 2026.
- Increasing consumer awareness and acceptance of AquAdvantage Salmon.
What Are the Key Risks for AQB?
- Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Negative consumer perception of genetically engineered food impacting demand.
- Regulatory hurdles and delays in obtaining approvals in new markets.
- Competition from established salmon producers with greater resources.
- Disease outbreaks in aquaculture facilities affecting production volume.
What Are the Growth Opportunities for AQB?
- Expansion of Production Capacity: AquaBounty can increase its revenue by expanding its production facilities and increasing the volume of AquAdvantage Salmon it can bring to market. This includes scaling up existing facilities and potentially building new ones in strategic locations. The global aquaculture market is projected to reach $285 billion by 2030, providing a substantial opportunity for growth if AquaBounty can capture a larger share of the salmon market. This expansion is dependent on securing additional funding and navigating regulatory approvals.
- Geographic Market Expansion: AquaBounty has the opportunity to expand its sales and distribution network beyond its current markets in the United States and Canada. Entering new markets, such as Europe and Asia, could significantly increase its revenue potential. The European salmon market, for example, is a large and established market with a growing demand for sustainable seafood options. This expansion requires navigating different regulatory environments and consumer preferences.
- Product Diversification: While AquAdvantage Salmon is the company's primary product, AquaBounty could explore opportunities to diversify its product line. This could include developing other genetically engineered fish species or offering value-added salmon products. Diversification could reduce the company's reliance on a single product and open up new revenue streams. The market for value-added seafood products is growing, driven by consumer demand for convenient and healthy meal options.
- Strategic Partnerships and Acquisitions: AquaBounty could pursue strategic partnerships or acquisitions to accelerate its growth and expand its capabilities. Partnering with established seafood distributors or acquiring smaller aquaculture companies could provide access to new markets and technologies. The aquaculture industry is consolidating, with larger companies acquiring smaller players to gain market share and expertise. These partnerships could facilitate faster market penetration and technology adoption.
- Technological Advancements: AquaBounty can continue to invest in research and development to further improve the efficiency and sustainability of its aquaculture operations. This could include developing new genetic modifications to enhance fish growth and disease resistance, as well as implementing advanced monitoring and control systems to optimize production. Technological advancements can lead to lower production costs and improved product quality, giving AquaBounty a competitive advantage.
What Opportunities Does AQB Have?
- Expansion of production facilities.
- Entry into new geographic markets.
- Development of new genetically engineered fish species.
- Strategic partnerships and acquisitions.
What Threats Does AQB Face?
- Competition from established salmon producers.
- Changes in consumer preferences.
- Unfavorable regulatory changes.
- Disease outbreaks in aquaculture facilities.
What Are AQB's Competitive Advantages?
- Proprietary AquAdvantage Salmon technology protected by patents.
- First-mover advantage in the genetically engineered salmon market.
- Specialized expertise in aquaculture and genetic engineering.
- Regulatory approvals for AquAdvantage Salmon in key markets.
What Does AQB Do?
AquaBounty Technologies, Inc., established in 1991 and headquartered in Maynard, Massachusetts, is a biotechnology company dedicated to improving productivity within the commercial aquaculture sector. Originally named Aqua Bounty Farms, Inc., the company rebranded in 2004 to reflect its focus on technological advancements. AquaBounty's core product is AquAdvantage Salmon, a genetically engineered Atlantic salmon designed for human consumption. This salmon grows faster than conventional Atlantic salmon, potentially reducing the time and resources required for production. The company engages in genetic, genomic, and fish health and nutrition research to further enhance its aquaculture offerings. In addition to AquAdvantage Salmon, AquaBounty sells conventional Atlantic salmon, salmon eggs, fry, and byproducts. The company aims to address the growing global demand for seafood through sustainable and efficient aquaculture practices. AquaBounty targets markets in the United States and Canada, seeking to establish its AquAdvantage Salmon as a viable and environmentally responsible alternative to traditional salmon farming.
What Products and Services Does AQB Offer?
- Develop and commercialize genetically engineered Atlantic salmon (AquAdvantage Salmon).
- Conduct genetic, genomic, and fish health research.
- Sell AquAdvantage Salmon for human consumption.
- Sell conventional Atlantic salmon.
- Sell salmon eggs and fry.
- Sell salmon byproducts.
How Does AQB Make Money?
- Generate revenue through the sale of AquAdvantage Salmon.
- Generate revenue through the sale of conventional Atlantic salmon, salmon eggs, and fry.
- Invest in research and development to improve aquaculture productivity.
- Focus on markets in the United States and Canada.
What Industry Does AQB Operate In?
AquaBounty Technologies operates within the agricultural farm products industry, a segment of the broader consumer defensive sector. The aquaculture industry is experiencing growth driven by increasing global demand for seafood and concerns about the sustainability of wild-caught fish. AquaBounty's AquAdvantage Salmon aims to address these trends by offering a more efficient and potentially more sustainable alternative to traditional salmon farming. Competitors include established salmon producers and other aquaculture companies. The company's success depends on its ability to differentiate its product and gain market share in a competitive landscape.
Who Are AQB's Key Customers?
- Seafood distributors
- Retail grocery chains
- Restaurants
- Consumers
Company Profile
AquaBounty Technologies, Inc. operates in the Agricultural Farm Products industry within the Consumer Defensive sector. It is headquartered in Maynard, US. The company is led by CEO David A. Frank. AQB has traded publicly since 2017.
FY2026 estForward Outlook
Wall Street analysts project AquaBounty Technologies, Inc. revenue of about $500K for fiscal 2026, with EPS near $-7.28.
F-Score 2/9Financial Health
AquaBounty Technologies, Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
AQB Valuation & Market Position
With a $3.96M market cap, AquaBounty Technologies, Inc. sits in the micro-cap segment of the market. Relative to its peer group, AQB's quantitative score of 24/100 is below the peer average of 61/100.
Net buyingInsider Activity
The most recent 12 insider filings for AquaBounty Technologies, Inc. break down as 5 sales and 7 purchases. On net that is roughly 105K shares acquired (about $88K) — insiders putting money in tends to read as conviction.
AQB Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Innovative AquAdvantage Salmon technology.
- First mover advantage in GE salmon market.
- Strong intellectual property protection.
- Focus on sustainable aquaculture practices.
Bear Case
- Limited production capacity.
- Dependence on a single product.
- Negative consumer perception of genetically engineered food.
- Regulatory hurdles in new markets.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
AQB Latest News
-
12 Health Care Stocks Moving In Monday's Intraday Session
benzinga · Oct 6, 2025
-
Stocks That Hit 52-Week Lows On Tuesday
· Feb 11, 2020
AQB Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for AQB.
Price Targets
Wall Street price target analysis for AQB.
AQB MoonshotScore
What does this score mean?
The MoonshotScore rates AQB's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Classification
Industry Agricultural Farm ProductsLeadership: David A. Frank
Chief Executive Officer
David A. Frank serves as the Chief Executive Officer of AquaBounty Technologies, Inc. His background includes extensive experience in the aquaculture and biotechnology industries. He has held various leadership positions in companies focused on developing and commercializing innovative technologies for food production. His expertise spans areas such as strategic planning, business development, and operations management. Frank's experience is crucial for guiding AquaBounty through its growth phase and navigating the complexities of the regulatory landscape for genetically engineered food products.
Track Record: Under David A. Frank's leadership, AquaBounty has focused on scaling up production of AquAdvantage Salmon and expanding its market reach. Key achievements include securing regulatory approvals in new markets and increasing consumer awareness of the benefits of genetically engineered salmon. He has also overseen investments in research and development to further improve the efficiency and sustainability of AquaBounty's aquaculture operations. His strategic decisions have positioned the company for long-term growth in the evolving aquaculture industry.
Common Questions About AQB (Consumer Defensive)
What does AquaBounty Technologies, Inc. do?
AquaBounty Technologies, Inc. is a biotechnology company focused on enhancing productivity in the commercial aquaculture industry. Its primary product is AquAdvantage Salmon, a genetically engineered Atlantic salmon designed to grow faster than conventional salmon. The company sells AquAdvantage Salmon, conventional Atlantic salmon, salmon eggs, and fry. AquaBounty aims to address the growing global demand for seafood through sustainable and efficient aquaculture practices, targeting markets in the United States and Canada. The company also engages in genetic, genomic, and fish health research.
What do analysts say about AQB stock?
Given AquaBounty's $3.96M market cap, analyst coverage may be limited. However, key considerations for valuation include the potential market size for AquAdvantage Salmon, the company's ability to scale production, and the regulatory landscape for genetically engineered food. Growth prospects depend on expanding production capacity, securing regulatory approvals in new markets, and increasing consumer acceptance of the product. Investors should monitor the company's financial performance, including revenue growth, production costs, and cash flow.
What are the main risks for AQB?
AquaBounty faces several risks, including negative consumer perception of genetically engineered food, which could limit demand for AquAdvantage Salmon. Regulatory hurdles and delays in obtaining approvals in new markets could also impede growth. The company faces competition from established salmon producers with greater resources and brand recognition. Additionally, disease outbreaks in aquaculture facilities could disrupt production and impact financial performance. These risks are compounded by the company's relatively small size and limited financial resources.
What are the key factors to evaluate for AQB?
AquaBounty Technologies, Inc. (AQB) holds an AI score of 24/100 (low). Not financial advice.
How frequently does AQB data refresh on this page?
AQB prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven AQB's recent stock price performance?
AquaBounty Technologies, Inc. (AQB) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Innovative AquAdvantage Salmon technology. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider AQB overvalued or undervalued right now?
Valuing AquaBounty Technologies, Inc. (AQB) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying AQB?
Before investing in AquaBounty Technologies, Inc. (AQB), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited financial data available.
- Future performance depends on regulatory approvals and market acceptance.